ZBD(SH:603567) Shang Hai Zheng Quan Bao·2025-08-11 19:18Group 1 - The company announced a cash dividend distribution of 0.15 yuan per share for the fiscal year 2024, approved at the annual shareholders' meeting on June 25, 2025 [2][4] - The total cash dividend distribution amounts to approximately 141.13 million yuan, based on a total share capital of 940,996,515 shares, excluding shares held in the repurchase account [4][6] - The dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch as of the close of trading on the record date [3][4] Group 2 - The company plans to postpone the completion dates for two fundraising investment projects: the "Jixi Branch Phase III Construction Project" to August 2026 and the "Traditional Chinese Medicine Material Processing Project" to October 2026 [11][22] - The postponement is due to external environmental factors affecting project progress, and the company aims to enhance the quality of the investment projects [22][25] - The board of directors approved the postponement during the meeting held on August 11, 2025, and the decision will be submitted for approval at the upcoming shareholders' meeting [26][36] Group 3 - The company intends to provide a guarantee for its wholly-owned subsidiary, Heilongjiang Zhenbaodao Medical Trade Co., Ltd., for bank financing up to 400 million yuan [29][30] - The guarantee is deemed necessary to support the subsidiary's operational needs, with the board considering the risk to be manageable [35][36] - The total amount of external guarantees provided by the company is 1.791 billion yuan, which accounts for 22.96% of the latest audited net assets [37]